Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market
The stock's rise snapped a four-day losing streak.
Fintel on MSN17h
Stifel Downgrades Vertex (VERX)
Fintel reports that on February 28, 2025, Stifel downgraded their outlook for Vertex (NasdaqGM:VERX) from Buy to Hold.
Vertex price target lowered to $41 from $56 at BMO Capital
BMO Capital analyst Daniel Jester lowered the firm’s price target on Vertex (VERX) to $41 from $56 and keeps a Market Perform rating on the shares. The firm had previously indicated that shares had ...
Vertex, Inc. (NASDAQ:VERX) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Vertex, Inc. (NASDAQ:VERX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the company, MarketBeat.com reports.
Vertex Pharma wins EU backing to expand label for Kaftrio cystic fibrosis drug
Vertex Pharmaceuticals (NASDAQ:VRTX) announced Friday that an expert panel of the EU drug regulator, the European Medicines ...
SurgeGraph Releases Free AI Humanizer Tool For Public Use
Federal Territory of Kuala Lumpur, Malaysia, February 28, 2025 -- SurgeGraph, an AI writing tool focused on helping users ...
Bennington Banner20hOpinion
Commentary: The Truth of the Matter: Let's stop talking and start building
In Vermont, no day goes by without another news story about the lack of affordable, workforce, and senior housing.
Indiatimes21h
Vertex Securities Share Price
Vertex Securities Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 32.71 Crore) operating in Financial Services sector. Vertex Securities Ltd. key ...